News & Trends - MedTech & Diagnostics
Surgeons welcome ‘significant win’ for patients, amidst clash with health insurers

MedTech & Diagnostics News: The Royal Australasian College of Surgeons (RACS) is heralding a significant triumph for Australian patients following the federal government’s announcement that health insurers will remain obligated to cover the expenses of vital surgical items.
This announcement comes in the wake of concerted lobbying led by the RACS, alongside the Australian Private Hospitals Association (APHA), Medical Technology Association of Australia (MTAA) and Australian Medical Association (AMA). Health Minister Mark Butler’s confirmation of insurers’ responsibility to fund General Use Items (GUI) represents a shield for patients against out-of-pocket expenses, especially amidst the current surge in the cost of living.
Previously, a policy shift threatened to abolish mandatory coverage for General Use Items (GUI) such as sutures, staples, and sealants from July 1, 2024. This move could have precipitated either escalated gap fees for patients or heightened financial pressure on private hospitals.
“This decision is a significant win for Australians,” said Professor Mark Ashton, who is a member of the RACS Health Policy and Advocacy Committee. “It safeguards patients from additional financial stress when accessing essential surgical care.”
In response, Rachel David, CEO of Private Healthcare Australia, articulated, “What we have now is a funding system that is commercially driven where the incentive is to drive more volume growth of generic items that are already significantly overpriced in Australia vs world markets. Claims integrity of the Prescribed List (PL) items is now the priority.”
In a rebuttal, John Cunningham OAM, Spine Surgeon, retorted, “You’re the CEO of the organisation charged with representing private health insurance companies and protecting their profits.”
RACS has also been actively engaged in consultations with the government regarding reforms to the Prescribed List (previously Prostheses List). Over the past two years, the College has consistently underscored the significance of preserving access and options for commonly utilised surgical supplies.
“Our focus has been on ensuring these reforms don’t restrict access to essential items,” explained Professor Ashton. “We particularly cautioned against a ‘bundling’ model that could limit patient choice.”
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals

Clinicians call for closer monitoring of patients post CAR T therapy
Australian clinicians are raising questions about whether cancer patients need closer monitoring after receiving CAR T-cell therapy. A Peter MacCallum […]
MoreNews & Trends - MedTech & Diagnostics

Next-gen surgical mesh to fill critical gap after regulatory ban
Next-generation urogynaecological surgical mesh implants are on the horizon for women suffering from pelvic organ prolapse (POP). This development aims […]
MoreNews & Trends - Pharmaceuticals

Contraceptive lawsuit against Bayer fails
The Victorian Supreme Court has dismissed a class action against Bayer for an allegedly defective contraceptive device. Justice Andrew Keogh […]
MoreNews & Trends - Pharmaceuticals

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse
The New South Wales Labor government’s plan to “redesign” the state’s mental health system, while excluding psychiatrists, has sparked intense […]
More